BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 8751097)

  • 1. Protein C, protein S, and antithrombin III in acute ocular occlusive diseases.
    Bertram B; Remky A; Arend O; Wolf S; Reim M
    Ger J Ophthalmol; 1995 Nov; 4(6):332-5. PubMed ID: 8751097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hereditary deficiency of antithrombin III, protein C, protein S and factor XII in 121 patients with venous or arterial thrombosis].
    Miljić P; Rolović Z; Elezović I; Antunović P; Stanojević M; Colović M
    Srp Arh Celok Lek; 1999; 127(1-2):21-7. PubMed ID: 10377836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amaurosis fugax in ocular vascular occlusive disorders: prevalence and pathogeneses.
    Hayreh SS; Zimmerman MB
    Retina; 2014 Jan; 34(1):115-22. PubMed ID: 23632956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The deficiencies of protein C, protein S and antithrombin III in patients with retinal vein occlusion: a Turkish sample.
    Ates O
    Clin Lab Haematol; 2006 Dec; 28(6):391-2. PubMed ID: 17105492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High long-term absolute risk of recurrent venous thromboembolism in patients with hereditary deficiencies of protein S, protein C or antithrombin.
    Brouwer JL; Lijfering WM; Ten Kate MK; Kluin-Nelemans HC; Veeger NJ; van der Meer J
    Thromb Haemost; 2009 Jan; 101(1):93-9. PubMed ID: 19132194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary deficiency of antithrombin III, protein C and protein S: prevalence in patients with a history of venous thrombosis and criteria for rational patient screening.
    Pabinger I; Brücker S; Kyrle PA; Schneider B; Korninger HC; Niessner H; Lechner K
    Blood Coagul Fibrinolysis; 1992 Oct; 3(5):547-53. PubMed ID: 1450321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalent misconceptions about acute retinal vascular occlusive disorders.
    Hayreh SS
    Prog Retin Eye Res; 2005 Jul; 24(4):493-519. PubMed ID: 15845346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhibitors of blood coagulation in vascular occlusion of the retina and optic nerve].
    Krüger K; Witt I
    Fortschr Ophthalmol; 1990; 87(2):178-81. PubMed ID: 2141589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hereditary disorders of the protein C system in central artery and branch arteriolar occlusions].
    Greiner K; Hafner G; Prellwitz W; Pfeiffer N
    Klin Monbl Augenheilkd; 1999 Jul; 215(1):33-6. PubMed ID: 10448635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different incidence of venous thrombosis in patients with inherited deficiencies of antithrombin III, protein C and protein S.
    Finazzi G; Barbui T
    Thromb Haemost; 1994 Jan; 71(1):15-8. PubMed ID: 8165635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary deficiencies of antithrombin III, protein S, and the protein C pathway in Jordanian thrombosis patients.
    Eid SS
    Clin Lab Sci; 2002; 15(4):196-9. PubMed ID: 12776777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular vascular thrombotic events: central retinal vein and central retinal artery occlusions.
    Glueck CJ; Ping Wang ; Hutchins R; Petersen MR; Golnik K
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):286-94. PubMed ID: 18160589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiphospholipid antibodies in ocular arterial and venous occlusive disease.
    Palmowski-Wolfe AM; Denninger E; Geisel J; Pindur G; Ruprecht KW
    Ophthalmologica; 2007; 221(1):41-6. PubMed ID: 17183200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occurrence of arterial thrombosis in a cohort of patients with hereditary deficiency of clotting inhibitors.
    Simioni P; Zanardi S; Saracino A; Girolami A
    J Med; 1992; 23(1):61-74. PubMed ID: 1533414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venous thrombosis: prevalence of prothrombotic defects in north Indian population.
    Bhattacharyya M; Kannan M; Chaudhry VP; Saxena R
    Indian J Pathol Microbiol; 2003 Oct; 46(4):621-4. PubMed ID: 15025358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of hyperhomocystinemia in retinal vascular occlusive disease.
    Sottilotta G; Oriana V; Latella C; Luise F; Piromalli A; Ramirez F; Mammi C; Occhiuto A; Lombardo VT
    Clin Appl Thromb Hemost; 2007 Jan; 13(1):104-7. PubMed ID: 17164500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenteric venous thrombosis due to antithrombin III deficiency.
    Maung R; Kelly JK; Schneider MP; Poon MC
    Arch Pathol Lab Med; 1988 Jan; 112(1):37-9. PubMed ID: 3337617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis.
    Heijboer H; Brandjes DP; Büller HR; Sturk A; ten Cate JW
    N Engl J Med; 1990 Nov; 323(22):1512-6. PubMed ID: 2146503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated protein C resistance is a risk factor for central retinal vein occlusion.
    Marcucci R; Bertini L; Liotta AA; Rogolino A; Antonucci E; Ilari I; Pepe G; Prisco D
    Ann Ital Med Int; 2000; 15(3):195-8. PubMed ID: 11059059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein C, protein S and antithrombin III deficiencies in retinal vein occlusion.
    Tekeli O; Gürsel E; Buyurgan H
    Acta Ophthalmol Scand; 1999 Dec; 77(6):628-30. PubMed ID: 10634552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.